Reagents and consumables

Ended Awarded Last action

Contract number
75N91019F00138
Awardee
Awarding agency
Obligated
$11,248

Award facts

Opportunity
Contract value 100% obligated
$11,248.12 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Indianapolis, IN 46250, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on June 25, 2019, with a ceiling value of $11,248.12 for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers.

Place of performance is Castleton, IN. The order is priced on a firm fixed-price basis with an ultimate completion date of July 24, 2019. No set-aside was used.

Quick answers

Who was awarded contract 75N91019F00138?

75N91019F00138 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on June 25, 2019.

How much is contract 75N91019F00138 worth?

The government has obligated $11,248 on 75N91019F00138.

Is contract 75N91019F00138 an order under another contract?

Yes. 75N91019F00138 is a delivery order under HHSN261201700010I, an indefinite delivery contract.

Was contract 75N91019F00138 competed?

The extent of competition for 75N91019F00138 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login